Home » Analyst Articles – US
Septerna (NASDAQ:SEPN) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Septerna (NASDAQ:SEPN – Get Free Report) had its target price upped by equities researchers at JPMorgan Chase & Co. from $48.00 to $51.00 in a research report issued to clients and investors on Thursday, Benzinga reports.... More of this article »
Woodward (NASDAQ:WWD) Stock Price Expected to Rise, UBS Group Analyst Says
Woodward (NASDAQ:WWD – Get Free Report) had its price target lifted by research analysts at UBS Group from $455.00 to $467.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has a “buy”... More of this article »
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Sarepta Therapeutics (NASDAQ:SRPT) Stock
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target raised by investment analysts at JPMorgan Chase & Co. from $20.00 to $22.00 in a report released on Thursday, Benzinga reports. The brokerage presently... More of this article »
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Xencor (NASDAQ:XNCR) Stock
Xencor (NASDAQ:XNCR – Get Free Report) had its price objective hoisted by equities research analysts at JPMorgan Chase & Co. from $21.00 to $37.00 in a research report issued to clients and investors on Thursday, Benzinga... More of this article »
Semtech (NASDAQ:SMTC) Stock Price Target Cut by Susquehanna
Semtech (NASDAQ:SMTC – Get Free Report) had its target price lowered by equities research analysts at Susquehanna from $200.00 to $170.00 in a research report issued to clients and investors on Thursday, MarketBeat.com reports.... More of this article »
Research Solutions (NASDAQ:RSSS) Stock Rating Lowered by Maxim Group
Research Solutions (NASDAQ:RSSS – Get Free Report) was downgraded by analysts at Maxim Group from a “buy” rating to a “hold” rating in a research report issued on Thursday, MarketBeat.com reports. Separately,... More of this article »
Barclays Issues Pessimistic Forecast for Workday (NASDAQ:WDAY) Stock Price
Workday (NASDAQ:WDAY – Get Free Report) had its price objective decreased by equities research analysts at Barclays from $224.00 to $223.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently... More of this article »SoundThinking (NASDAQ:SSTI) Coverage Dropped by Analysts at Cantor Fitzgerald
Cantor Fitzgerald dropped coverage on shares of SoundThinking (NASDAQ:SSTI – Get Free Report) in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage had previously set a “neutral”... More of this article »
Zai Lab (NASDAQ:ZLAB) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Zai Lab (NASDAQ:ZLAB – Get Free Report) had its price target lifted by JPMorgan Chase & Co. from $36.00 to $37.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “overweight”... More of this article »
Cartesian Therapeutics (NASDAQ:RNAC) Stock Rating Reaffirmed as “Buy” by HC Wainwright
Cartesian Therapeutics (NASDAQ:RNAC – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research report issued to clients and investors on Thursday,... More of this article »
Privia Health Group (NASDAQ:PRVA) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says
Privia Health Group (NASDAQ:PRVA – Get Free Report) had its price objective boosted by research analysts at Royal Bank Of Canada from $31.00 to $32.00 in a report issued on Thursday, Benzinga reports. The brokerage currently... More of this article »
JPMorgan Chase & Co. Issues Pessimistic Forecast for XP (NASDAQ:XP) Stock Price
XP (NASDAQ:XP – Get Free Report) had its price target cut by research analysts at JPMorgan Chase & Co. from $38.00 to $18.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “overweight”... More of this article »
HC Wainwright Reaffirms “Buy” Rating for Scribe Therapeutics (NASDAQ:SCTX)
Scribe Therapeutics (NASDAQ:SCTX – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a note issued to investors on Thursday, Benzinga reports. They presently have a $60.00 price objective... More of this article »
B. Riley Financial Issues Pessimistic Forecast for Prenetics Global (NASDAQ:PRE) Stock Price
Prenetics Global (NASDAQ:PRE – Get Free Report) had its price target decreased by investment analysts at B. Riley Financial from $37.00 to $31.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently... More of this article »
Wall Street Zen Upgrades Labcorp (NYSE:LH) to Strong-Buy
Labcorp (NYSE:LH – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report released on Saturday, Wall Street Zen reports. Several... More of this article »
Research Analysts Set Expectations for TMS FY2026 Earnings
Live Oak Acquisition Corp. V (NASDAQ:TMS – Free Report) – Equities research analysts at Northland Securities decreased their FY2026 EPS estimates for Live Oak Acquisition Corp. V in a research note issued on Tuesday, November... More of this article »
Equities Analysts Offer Predictions for TMS FY2026 Earnings
Live Oak Acquisition Corp. V (NASDAQ:TMS – Free Report) – Research analysts at Sidoti reduced their FY2026 EPS estimates for Live Oak Acquisition Corp. V in a research note issued to investors on Tuesday, November 17th.... More of this article »
Research Analysts Offer Predictions for CLB FY2026 Earnings
Core Laboratories Inc. (NYSE:CLB – Free Report) – Investment analysts at Zacks Research cut their FY2026 earnings estimates for Core Laboratories in a research report issued on Wednesday, November 18th. Zacks Research... More of this article »
Q4 EPS Forecast for Targa Resources Raised by Analyst
Targa Resources, Inc. (NYSE:TRGP – Free Report) – Research analysts at US Capital Advisors increased their Q4 2026 EPS estimates for Targa Resources in a report released on Tuesday, November 17th. US Capital Advisors analyst... More of this article »
What is Noble Financial’s Estimate for BBGI FY2026 Earnings?
Beasley Broadcast Group, Inc. (NASDAQ:BBGI – Free Report) – Equities research analysts at Noble Financial raised their FY2026 earnings per share (EPS) estimates for shares of Beasley Broadcast Group in a report released... More of this article »
HC Wainwright Has Negative View of Altimmune FY2026 Earnings
Altimmune, Inc. (NASDAQ:ALT – Free Report) – Equities research analysts at HC Wainwright reduced their FY2026 earnings estimates for shares of Altimmune in a research note issued to investors on Tuesday, November 17th.... More of this article »
FY2026 EPS Forecast for Dare Bioscience Increased by Analyst
Dare Bioscience, Inc. (NASDAQ:DARE – Free Report) – Equities research analysts at Brookline Capital Markets boosted their FY2026 EPS estimates for Dare Bioscience in a research report issued to clients and investors on... More of this article »
FY2026 EPS Estimates for Avantor Increased by Zacks Research
Avantor, Inc. (NYSE:AVTR – Free Report) – Zacks Research upped their FY2026 EPS estimates for Avantor in a research note issued on Wednesday, November 18th. Zacks Research analyst Team now forecasts that the company will... More of this article »
